SBI Securities Co. Ltd. lowered its stake in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 80.0% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 1,669 shares of the technology company’s stock after selling 6,688 shares during the quarter. SBI Securities Co. Ltd.’s holdings in Veeva Systems were worth $481,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. Trust Co. of Toledo NA OH purchased a new position in Veeva Systems during the 2nd quarter worth $29,000. Legacy Investment Solutions LLC purchased a new position in Veeva Systems during the second quarter worth about $32,000. Maseco LLP purchased a new position in Veeva Systems during the second quarter worth about $35,000. Ameritas Advisory Services LLC bought a new stake in Veeva Systems in the 2nd quarter worth about $68,000. Finally, ORG Partners LLC increased its stake in Veeva Systems by 176.3% in the 2nd quarter. ORG Partners LLC now owns 315 shares of the technology company’s stock valued at $89,000 after buying an additional 201 shares during the last quarter. 88.20% of the stock is owned by hedge funds and other institutional investors.
Veeva Systems Stock Performance
VEEV stock opened at $293.24 on Friday. The stock has a fifty day moving average of $288.89 and a 200-day moving average of $277.35. Veeva Systems Inc. has a fifty-two week low of $201.54 and a fifty-two week high of $310.50. The company has a market capitalization of $48.06 billion, a price-to-earnings ratio of 60.21, a PEG ratio of 2.22 and a beta of 0.98.
Insider Activity at Veeva Systems
In other Veeva Systems news, insider Thomas D. Schwenger sold 3,350 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $300.04, for a total transaction of $1,005,134.00. Following the sale, the insider owned 23,773 shares in the company, valued at $7,132,850.92. This represents a 12.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Jonathan Faddis sold 720 shares of the firm’s stock in a transaction on Monday, October 6th. The stock was sold at an average price of $298.12, for a total value of $214,646.40. Following the completion of the transaction, the senior vice president directly owned 7,868 shares of the company’s stock, valued at $2,345,608.16. The trade was a 8.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 24,665 shares of company stock worth $7,438,000. 10.30% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on VEEV shares. William Blair restated an “outperform” rating on shares of Veeva Systems in a research note on Friday, October 17th. Truist Financial boosted their price objective on Veeva Systems from $268.00 to $275.00 and gave the stock a “hold” rating in a research report on Thursday, August 28th. Mizuho upped their price objective on Veeva Systems from $295.00 to $325.00 and gave the company an “outperform” rating in a research note on Friday, August 29th. Evercore ISI lifted their target price on Veeva Systems from $285.00 to $295.00 and gave the stock an “in-line” rating in a research note on Thursday, August 28th. Finally, Canaccord Genuity Group increased their price target on shares of Veeva Systems from $270.00 to $300.00 and gave the company a “hold” rating in a research report on Thursday, August 28th. Seventeen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $307.28.
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Read More
- Five stocks we like better than Veeva Systems
- How to Profit From Value Investing
- Are These 3 Oversold Tech Giants Ready to Rebound?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- If You Wait for the Dip, Micron Technology Could Leave You Behind
- The 3 Best Fintech Stocks to Buy Now
- 3 Stocks Quietly Powering the AI and Tech Revolution
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
